MicroPort Endovascular MedTech Ltd (688016) - Total Assets
Based on the latest financial reports, MicroPort Endovascular MedTech Ltd (688016) holds total assets worth CN¥4.64 Billion CNY (≈ $679.15 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See net assets of MicroPort Endovascular MedTech Ltd for net asset value and shareholders' equity analysis.
MicroPort Endovascular MedTech Ltd - Total Assets Trend (2016–2025)
This chart illustrates how MicroPort Endovascular MedTech Ltd's total assets have evolved over time, based on quarterly financial data.
MicroPort Endovascular MedTech Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
MicroPort Endovascular MedTech Ltd's total assets of CN¥4.64 Billion consist of 60.4% current assets and 39.6% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 43.2% |
| Accounts Receivable | CN¥368.08 Million | 7.9% |
| Inventory | CN¥272.30 Million | 5.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥603.25 Million | 13.0% |
| Goodwill | CN¥465.25 Million | 10.0% |
Asset Composition Trend (2016–2025)
This chart illustrates how MicroPort Endovascular MedTech Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is MicroPort Endovascular MedTech Ltd worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: MicroPort Endovascular MedTech Ltd's current assets represent 60.4% of total assets in 2025, an increase from 40.4% in 2016.
- Cash Position: Cash and equivalents constituted 43.2% of total assets in 2025, up from 14.7% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 23.0% of total assets, a decrease from 27.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 13.0% of total assets.
MicroPort Endovascular MedTech Ltd Competitors by Total Assets
Key competitors of MicroPort Endovascular MedTech Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.54 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
Shanghai Kinetic Medical Co
SHE:300326
|
China | CN¥3.38 Billion |
|
Eurobio Scientific SA
PA:ALERS
|
France | €259.11 Million |
|
EBR Systems Inc
AU:EBR
|
Australia | AU$97.29 Million |
|
PULSION Medical Systems SE
MU:PUS
|
Germany | €35.15 Million |
|
Aroa Biosurgery Ltd
AU:ARX
|
Australia | AU$95.27 Million |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033
|
China | CN¥805.10 Million |
MicroPort Endovascular MedTech Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.85 | 8.08 | 8.39 |
| Quick Ratio | 6.18 | 7.30 | 7.84 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥2.39 Billion | CN¥2.40 Billion | CN¥1.17 Billion |
MicroPort Endovascular MedTech Ltd - Advanced Valuation Insights
This section examines the relationship between MicroPort Endovascular MedTech Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.01 |
| Latest Market Cap to Assets Ratio | 0.39 |
| Asset Growth Rate (YoY) | 8.1% |
| Total Assets | CN¥4.64 Billion |
| Market Capitalization | $1.82 Billion USD |
Valuation Analysis
Below Book Valuation: The market values MicroPort Endovascular MedTech Ltd's assets below their book value (0.39x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: MicroPort Endovascular MedTech Ltd's assets grew by 8.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for MicroPort Endovascular MedTech Ltd (2016–2025)
The table below shows the annual total assets of MicroPort Endovascular MedTech Ltd from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥4.64 Billion ≈ $679.15 Million |
+8.15% |
| 2024-12-31 | CN¥4.29 Billion ≈ $628.00 Million |
+1.07% |
| 2023-12-31 | CN¥4.25 Billion ≈ $621.35 Million |
+112.83% |
| 2022-12-31 | CN¥2.00 Billion ≈ $291.95 Million |
+13.77% |
| 2021-12-31 | CN¥1.75 Billion ≈ $256.60 Million |
+27.43% |
| 2020-12-31 | CN¥1.38 Billion ≈ $201.36 Million |
+19.07% |
| 2019-12-31 | CN¥1.16 Billion ≈ $169.12 Million |
+329.93% |
| 2018-12-31 | CN¥268.82 Million ≈ $39.34 Million |
+19.87% |
| 2017-12-31 | CN¥224.26 Million ≈ $32.82 Million |
+18.91% |
| 2016-12-31 | CN¥188.60 Million ≈ $27.60 Million |
-- |
About MicroPort Endovascular MedTech Ltd
Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, and sale of aortic and peripheral vascular medical devices in China and internationally. The company offers branched aortic, thoracic, and bifurcated stent graft system; abdominal aortic stent graft and delivery system; and other stent graft system in surgical operation; as well as accessorie… Read more